COMPANY PROFILE

Pathwork Diagnostics

Explore full profile

And delivers molecular diagnostic solutions for oncology

Redwood City, United StatesFounded 2002Biotech & Life Sciences

Valuation $100–250M Last recorded · 2010

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Pathwork Diagnostics

Pathwork Diagnostics operates in the molecular diagnostics sector, focusing on developing and delivering advanced solutions for oncology. The company serves healthcare providers, including hospitals, clinics, and specialized cancer treatment centers, by offering diagnostic tools that enhance the detection and treatment of cancer. Pathwork Diagnostics leverages cutting-edge technology to provide accurate and timely diagnostic information, which is crucial for effective patient management and treatment planning. The business model revolves around the sale of diagnostic tests and related services, generating revenue through direct sales to healthcare institutions and partnerships with other medical organizations. By addressing the critical need for precise cancer diagnostics, Pathwork Diagnostics positions itself as a key player in the oncology diagnostics market.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2002
Headquarters: Redwood City, United States
Employees: 9
Open positions: None listed
Dealroom signal: 24.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
FundingOther financing	Jan 2013	$0	—	Sand Hill Angels	—
SERIES DOther financing	Jan 2012	$0	—	Sand Hill Angels	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Pathwork Diagnostics website traffic

Latest recorded traffic for Pathwork Diagnostics is 160 monthly website visits, up 433.3% over the last three months. Pathwork Diagnostics's team grew 0% over the past year.

Latest monthly visits160 3-month web change+433.3% 1-year team growth0%

Monthly website visitsOct 2017–Apr 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational	11	$3.4M	$7M
FEFemtogenixDNA-interactive payloads for antibody-drug conjugates	St Albans, United Kingdom	Operational
GBGeneCast BiotechnologyIt is a Beijing cancer diagnosis company	Haidian, China	Operational
ANAnchorDxAnchorDx is a precision medicine firm	Guangzhou, China	Operational
GEGeneAdviserOur mission is to make genetic testing for rare diseases more accessible to clinicians around the world	Cambridge, United Kingdom	Operational
AGAtossa GeneticsHealthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients	Seattle, United States	Operational
PRPrevnosBiotechnology company operating within the in vitro diagnostics sector	Jersey City, United States	Operational
SBShield BioFighting antibiotic resistance with genomics	Santa Clara, United States	Closed